Department of Personality, Assessment and Psychological Treatments, Universitat de València, Valencia, Spain.
Faculty of Health Sciences, Valencian International University, Valencia, Spain.
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13692. doi: 10.1111/ecc.13692. Epub 2022 Sep 7.
To identify high-risk survivors in order to provide appropriate care.
To analyse the quality of life (QOL) of cancer survivors using an instrument designed specifically for this population and considering different sociodemographic and disease-related characteristics as possible modulating variables.
The Quality of Life in Adult Cancer Survivors (QLACS) was filled out by a large and heterogeneous sample of disease-free post-treatment Spanish cancer survivors (N = 1862).
QLACS scores were comparable to those obtained in other studies and indicative of worse QOL as a function of shorter elapsed time since the end of primary treatment. The best QOL was shown by prostate, and the worst by hematologic cancer survivors. Both systemic treatments (chemotherapy and hormone therapy) and the combination of radiotherapy and chemotherapy were associated with worse QOL. Likewise, younger age, female sex, unemployment status and not having a stable partner were associated with worse QOL.
Greater understanding of the QOL experienced by the already large and continuously growing population of cancer survivors is relevant for guiding both clinical practice and health policy. In addition, knowing the risk factors associated with worse QOL facilitates the development of targeted prevention programmes for those survivors who need it the most.
为了确定高危幸存者，以便提供适当的护理。
使用专为该人群设计的工具分析癌症幸存者的生活质量（QOL），并考虑不同的社会人口学和与疾病相关的特征作为可能的调节变量。
使用一种大型的、异质的、无疾病的西班牙癌症幸存者（N=1862）治疗后样本，填写成人癌症幸存者生活质量量表（QLACS）。
QLACS 评分与其他研究中获得的评分相当，表明随着主要治疗结束后时间的缩短，QOL 越差。前列腺癌幸存者的 QOL 最好，血液癌幸存者的最差。系统治疗（化疗和激素治疗）以及放射治疗和化疗的联合治疗与较差的 QOL 相关。同样，年龄较小、女性、失业状态和没有稳定伴侣与较差的 QOL 相关。
更好地了解已经庞大且不断增长的癌症幸存者群体所经历的 QOL，对于指导临床实践和卫生政策都很重要。此外，了解与较差 QOL 相关的风险因素有助于为最需要的幸存者制定有针对性的预防计划。
